LUNDBECK WORLDWIDE Global About us Disease areas Investor Careers CSR Media Meet Patricia and Eleanor Patricia Ekstrom has moved back home to take care of her mother. Eleanor has mild to moderate Alzheimer’s disease, and there’s a good reason why Patricia understands the job that lies ahead. Read the real life patient story here Latest releases Sep 24, 2016 ı Corporate Releases US FDA approves labeling update of Rexulti® (brexpiprazole) for maintenance treatment of... Sep 22, 2016 ı Corporate Releases Headline conclusions from the first out of three phase III studies on idalopirdine in... View all releases Join Lundbeck 3 3 4 4 8 8 9 9 Current open positions Browse global vacancies Q2 2016 results Lundbeck's Q2 2016 results have been released. Download the release. Listen to the replay of the investor presentation here. New corporate film Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. Latest feature September 2016: September 2016 will mark the 5th global World Alzheimer’s Month campaign. Read more Share price 217.1 DKK -1.048% Sep 30, 2016 16:59 (OMX: LUN) View share data Cookie Policy Page last modified 06 September 2016 H. Lundbeck A/S Ottiliavej 9 | 2500 | Valby | Denmark | Phone +45 3630 1311 | Fax +45 3630 1940 Sitemap | Contact us | Disclaimer and privacy statement Follow us on yYouTube tTwitter iLinkedIn